Concord Wealth Partners - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$105
-99.4%
3
-99.2%
0.00%
-100.0%
Q2 2022$19,000
-85.2%
366
-79.3%
0.01%
-84.8%
Q1 2022$128,000
-39.6%
1,767
-1.3%
0.03%
-36.5%
Q4 2021$212,000
+236.5%
1,791
+281.9%
0.05%
+100.0%
Q3 2021$63,000
-75.2%
469
-70.1%
0.03%
-64.4%
Q2 2021$254,000
+137.4%
1,570
+18.1%
0.07%
+102.8%
Q1 2021$107,000
+3466.7%
1,329
+2727.7%
0.04%
+1700.0%
Q4 2020$3,000470.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders